Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Understanding and Diagnosing Allergic Disease in Twins

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Stanford University
Sponsor:
Information provided by (Responsible Party):
Kari Christine Nadeau, Stanford University
ClinicalTrials.gov Identifier:
NCT01613885
First received: June 5, 2012
Last updated: November 24, 2015
Last verified: November 2015
  Purpose
The purpose of this study is to gain better understanding of how the immune system works in twins with and without allergic disease. Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies.

Condition
Allergies

Study Type: Observational
Official Title: Understanding and Diagnosing Allergic Disease in Twins

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Comparing immune systems of food allergic twins [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA
Blood

Estimated Enrollment: 200
Study Start Date: August 2010
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts
Twins, ages 0 to 80 years, with or without allergy disease.

  Eligibility

Ages Eligible for Study:   up to 80 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy volunteers are not specifically targeted. Healthy non-allergic study participants may be found through the course of evaluation for the presence of allergies. Women, minorities or children will not be excluded from this study.
Criteria

Inclusion Criteria:

  • Twin participants ages 0 to 80 years who are with or without allergy disease.

Exclusion Criteria:

  • Patients with special risks attendant to venipuncture will be excluded.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01613885

Contacts
Contact: Kari A Nadeau, MD, PhD snpcenterallergy.inquiry@stanford.edu

Locations
United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact       snpcenterallergy.inquiry@stanford.edu   
Principal Investigator: Kari C Nadeau, M.D., PhD.         
Stanford University Recruiting
Stanford, California, United States, 94305
Contact: Kari Nadeau, MD, PhD       snpcenterallergy.inquiry@stanford.edu   
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Kari Nadeau, MD, PhD Stanford University
  More Information

Responsible Party: Kari Christine Nadeau, Associate Professor, Stanford University
ClinicalTrials.gov Identifier: NCT01613885     History of Changes
Other Study ID Numbers: SU-10042011-8546 
Study First Received: June 5, 2012
Last Updated: November 24, 2015
Health Authority: United States: Food and Drug Administration
United States: Institutional Review Board

Additional relevant MeSH terms:
Diseases in Twins
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on September 28, 2016